Principia biopharma inc. (PRNB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities:
Net loss

-72,604

-53,792

-19,491

9,488

4,170

18,167

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of convertible preferred stock warrant liability

-

-

-

-

-

577

0

0

0

Amortization of discount on marketable securities

1,384

1,563

1,547

1,349

913

387

0

0

0

Depreciation

1,988

1,832

1,413

980

552

252

0

0

0

Stock-based compensation

14,366

12,182

10,310

7,744

4,640

2,801

0

0

0

Deferred rent

-797

-325

224

965

1,217

745

0

0

0

Non-cash lease expense

0

-

-

-

0

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

1,333

400

-618

-8,994

2,236

2,187

0

0

0

Deferred revenue

0

-5,160

-21,297

-34,861

-37,848

-44,137

0

0

0

Accounts payable

-2,274

-2,082

-1,919

1,142

1,980

1,034

0

0

0

Accrued liabilities

8,715

6,762

5,046

4,893

1,629

1,962

0

0

0

Lease liability

0

-

-

-

0

-

-

-

-

Net cash used in operating activities

-53,612

-42,546

-26,643

-1,936

-26,554

-21,173

0

0

0

Investing activities:
Purchases of property and equipment

973

2,171

2,766

2,612

2,290

1,067

0

0

0

Maturities of marketable securities

250,267

199,916

157,560

117,035

47,910

13,500

0

0

0

Purchases of marketable securities

381,577

380,368

248,402

244,464

195,835

159,299

0

0

0

Net cash provided by (used in) investing activities

-132,283

-182,623

-93,608

-130,041

-150,215

-146,866

0

0

0

Financing activities:
Net proceeds from equity offerings

-

-

-

-

-

-

-

-

0

Proceeds from issuances of common stock upon exercise of options and participation in employee stock purchase plan

4,178

3,661

0

0

0

-

-

-

-

Net cash provided by financing activities

230,652

230,135

527

163,029

161,822

161,941

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

44,757

4,966

-119,724

31,052

-14,947

-6,098

0

0

0

Supplemental disclosures of cash flow information
Non cash tenant improvement allowance used for leasehold improvements

0

8,324

0

8,324

8,324

0

0

0

0

Purchases of property and equipment accrued but not yet paid

-293

0

578

799

791

642

0

0

0